Large-scale testing (Phase 3)Study completedNCT00000117What this trial is testingIntravenous Immunoglobulin Therapy in Optic NeuritisWho this might be right forOptic Neuritis National Eye Institute (NEI)
Large-scale testing (Phase 3)UnknownNCT04395170What this trial is testingConvalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.Who this might be right forCoronavirus Disease 2019 (COVID-19) Lifefactors Zona Franca, SAS 75
Early research (Phase 1)Study completedNCT02350673What this trial is testingIntravenous (IV) Cergutuzumab Amunaleukin and Atezolizumab in Combination in Participants With Locally Advanced and/or Metastatic Solid TumorsWho this might be right forSolid Tumors Hoffmann-La Roche 70
Early research (Phase 1)Study completedNCT01035645What this trial is testingFirst Time in Human Study of Intravenous Interleukin-18 AntibodyWho this might be right forInflammatory Bowel Diseases GlaxoSmithKline 78
Post-approval studies (Phase 4)Study completedNCT06637072What this trial is testingAssess Adults With CIDP Transitioning From IVIg to Efgartigimod PH20 SCWho this might be right forChronic Inflammatory Demyelinating Polyneuropathy argenx 23
Early research (Phase 1)Study completedNCT00703469What this trial is testingMDX-1106 to Treat Patients With Hepatitis C InfectionWho this might be right forHepatitis C Bristol-Myers Squibb 54
Early research (Phase 1)Study completedNCT01614756What this trial is testingA Two-Part, Phase 1, Single-Dose Study of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody); in Healthy Subjects and Adults With Atopic DermatitisWho this might be right forHealthy Subjects and Atopic Dermatitis Subjects Bristol-Myers Squibb 93
Not applicableLooking for participantsNCT06183645What this trial is testingExploratory Study on Predicting CIDP Patients' Decline During IV Immunoglobulin Treatment Adaptation Feasibility.Who this might be right forChronic Inflammatory Demyelinating Polyneuropathy Centre Hospitalier Universitaire de Liege 40
Not applicableUnknownNCT04303962What this trial is testingEfficacy of Intravenous Gamma Globulin on Guillain-Barre SyndromeWho this might be right forGuillain-barre Syndrome Ning Wang, MD., PhD. 200
Early research (Phase 1)Looking for participantsNCT07181369What this trial is testingGTX-B001 in Healthy Subjects and Patients With Chronic Inducible UrticariaWho this might be right forHealthy SubjectsCold UrticariaSymptomatic Dermographism+1 more Granular Therapeutics Limited 72
Large-scale testing (Phase 3)Study completedNCT04302805What this trial is testingRATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation (INHIBIT)Who this might be right forKidney Transplantation Institute for Clinical and Experimental Medicine 17
Not applicableStudy completedNCT02629796What this trial is testingBiomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating PolyradiculoneuropathyWho this might be right forCIDP Fondation Ophtalmologique Adolphe de Rothschild 44
Post-approval studies (Phase 4)Ended earlyNCT00177970What this trial is testingIVIG Versus Placebo for the Treatment of Patients With Severe C-DiffWho this might be right forClostridium Difficile-associated Diarrhea (CDAD) University of Pittsburgh 14
Testing effectiveness (Phase 2)Study completedNCT04137224What this trial is testingSafety and Pharmacokinetics of IgPro20 and IgPro10 in Adults With Systemic Sclerosis (SSc)Who this might be right forDiffuse Cutaneous Systemic Sclerosis CSL Behring 27
Large-scale testing (Phase 3)Looking for participantsNCT06533098What this trial is testingNipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)Who this might be right forThrombocytopenia, Neonatal Alloimmune Janssen Research & Development, LLC 50
Post-approval studies (Phase 4)Study completedNCT01179893What this trial is testingIntravenous Immunoglobulin and Plasma Exchange in Myasthenia GravisWho this might be right forMyasthenia Gravid University Health Network, Toronto 87
Large-scale testing (Phase 3)Study completedNCT03961009What this trial is testingClinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in PID PatientsWho this might be right forPrimary Immunodeficiency Disease Kedrion S.p.A. 47
Large-scale testing (Phase 3)Ended earlyNCT00050375What this trial is testingClinical Trial for Ovarian Cancer (OvaRex®)Who this might be right forOvarian Cancer Unither Pharmaceuticals 354
Large-scale testing (Phase 3)Study completedNCT02374736What this trial is testingEffect of Privigen Against Graft LossWho this might be right forKidney Transplantation Assistance Publique - Hôpitaux de Paris 18
Early research (Phase 1)Study completedNCT00037011What this trial is testingBeta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic NeuroblastomaWho this might be right forNeuroblastoma Memorial Sloan Kettering Cancer Center